Viewing Study NCT04429594



Ignite Creation Date: 2024-05-06 @ 2:46 PM
Last Modification Date: 2024-10-26 @ 1:37 PM
Study NCT ID: NCT04429594
Status: RECRUITING
Last Update Posted: 2024-06-27
First Post: 2020-06-10

Brief Title: Study of the Incidence of SARS-CoV-2 Infection COVID-19
Sponsor: Centre Hospitalier Universitaire de Nice
Organization: Centre Hospitalier Universitaire de Nice

Study Overview

Official Title: Study of the Incidence of SARS-CoV-2 Infection in the Alpes-Maritimes Department by Analysis of the Specific Humoral and Cellular Response During Deconfinement
Status: RECRUITING
Status Verified Date: 2024-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CovImmune 2
Brief Summary: This is a prospective observational cohort study that will define the prevalence and incidence of CA-SARS-Cov2 infection using serological and PCR tests in a group of subjects during deconfinement The team wishes to include approximately 1000 subjects in this study

The health crisis through containment has also created unprecedented environmental conditions with the very clear decrease in economic activities and a consequent decrease in exposure to the main air pollutants The aim is therefore to carry out a case-control study in which each subject will be his or her own control in unexposed condition to PM25 PM10 NO then exposed after the recovery of economic activity and the usual levels of air pollutants and to measure the impact of these pollutants on the immune system and epigenetic markers taking into account seasonality

The occurrence of infectious cardiovascular allergic and autoimmune events will then be measured according to the immunological profiles measured at inclusion
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None